Fulcrum Therapeutics (FULC) Payables (2018 - 2026)
Fulcrum Therapeutics (FULC) recorded Payables of $3.43 million in Q2 2026, up 95.6% from $1.75 million a year earlier and up 39.8% from the prior quarter.
Powered by 
Analysis
Fulcrum Therapeutics (FULC) Payables (2018 - 2026) Analysis & Trends
At the end of FY2025, Fulcrum Therapeutics reported Payables of $1.59 million, up 36.8% from FY2024.
- Annual Payables has a five-year compound annual growth rate of -17.2% (FY2020 to FY2025).
- Across earlier years, Payables came in at $1.16 million in FY2024 (-57.8%), $2.76 million in FY2023 (-24.2%), $3.64 million in FY2022 (-24.0%) and $4.79 million in FY2021 (+17.4%).
- The Q2 2026 figure is the highest quarterly Payables since Q3 2024.
- On a year-over-year basis, Payables has increased for three consecutive quarters, with growth averaging 1.1% over the last eight quarters.
- Peak year-over-year performance for Payables in the last five years was growth of 95.6% in Q2 2026, against a decline of 60.9% in Q1 2025 at the low end.
- Per Business Quant, the preceding three quarters came in at $2.45 million (Q1 2026), $1.59 million (Q4 2025) and $2.86 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 5.79 Bn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 18.17 Bn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | 34.43 Bn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 7.17 Bn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | -25.19 Bn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 2.95 Bn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | 934.00 Mn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 4.07 Bn |
| 10 | Fulcrum Therapeutics | 283.78 Mn | -59.56 Mn | - | 5.94 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 5.94 Mn |
| Mar 31, 2026 | 4.91 Mn |
| Dec 31, 2025 | 4.00 Mn |
| Sep 30, 2025 | 5.20 Mn |
| Jun 30, 2025 | 4.04 Mn |
| Mar 31, 2025 | 3.75 Mn |
| Dec 31, 2024 | 3.35 Mn |
| Sep 30, 2024 | 6.18 Mn |
| Jun 30, 2024 | 5.67 Mn |
| Mar 31, 2024 | 5.89 Mn |
| Dec 31, 2023 | 4.95 Mn |
| Sep 30, 2023 | 5.92 Mn |
| Jun 30, 2023 | 6.42 Mn |
| Mar 31, 2023 | 6.44 Mn |
| Dec 31, 2022 | 6.24 Mn |
| Sep 30, 2022 | 5.27 Mn |
| Jun 30, 2022 | 7.87 Mn |
| Mar 31, 2022 | 8.43 Mn |
| Dec 31, 2021 | 4.79 Mn |
| Sep 30, 2021 | 3.74 Mn |
API Access
Fulcrum Therapeutics Payables API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=payables&ticker=FULC&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "payables", "ticker": "FULC", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=payables&ticker=FULC&period=max&api_key=YOUR_API_KEY");
const data = await res.json();